Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
2023 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (57)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (22)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (308)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (11)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (31)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (139)
University of California, San Francisco (125)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (723)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (319)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (302)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (132)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (346)
Closed (1110)
Pre-Active (25)
Institution
Researcher name
Grant Type
Grant Title
Award Value
City of Hope, Beckman Research Institute
Dr. Stephen J Forman
Early Translational III
Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells
$5,215,447
Gladstone Institutes, J. David
Dr. Deepak Srivastava
Early Translational III
Direct Cardiac Reprogramming for Heart Regeneration
$5,795,871
University of California, San Diego
Dr. Lawrence S. B. Goldstein
Early Translational III
Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells
$1,774,420
University of California, San Diego
Dr. Yang Xu
Early Translational III
Human ES cell based therapy of heart failure without allogenic immune rejection
$1,857,600
Stanford University
Dr. Joseph C. Wu
Early Translational III
Heart Repair with Human Tissue Engineered Myocardium
$4,395,080
University of California, San Francisco
Mort Cowan
Early Translational III
Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID
$3,862,367
Stanford University
Professor Helen M. Blau PhD
Early Translational III
Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients
$1,825,283
University of Southern California
Dr. Toshio Miki
Early Translational III
Generation of hepatic cell from placental stem cell for congenital metabolic disorders
$1,750,375
Children’s Hospital of Orange County
Dr. Philip H Schwartz
Early Translational III
Immune-Matched Neural Stem Cell Transplantation for Pediatric Neurodegenerative Disease
$4,266,015
University of California, San Francisco
Dr. Holger F Willenbring
Early Translational III
Generation of safe and therapeutically effective human induced hepatocyte-like cells
$1,544,170
Salk Institute for Biological Studies
Juan Carlos Izpisua Belmonte
Early Translational III
Direct reprogramming towards vascular progenitors for the treatment of ischemia
$2,340,000
University of California, San Diego
Dr. Eric D. Adler MD
Early Translational III
Identification of Novel Therapeutics for Danon Disease Using an iPS Model of the Disease
$1,701,575
University of California, Davis
Walter Douglas Boyd
Early Translational III
Extracellular Matrix Bioscaffold Augmented with Human Stem Cells for Cardiovascular Repair
$4,631,754
Stanford University
Dr. Bertha Chen
Early Translational III
Autologous iPSC Therapy for Urinary Incontinence
$4,715,738
University of California, San Diego
Mark H Tuszynski
Early Translational III
Functional Neural Relay Formation by Human Neural Stem Cell Grafting in Spinal Cord Injury
$4,600,447
University of California, Davis
Prof. Kyriacos A. Athanasiou Ph.D
Early Translational III
Tissue engineered cartilage from autologous, dermis-isolated, adult, stem (DIAS) cells
$1,735,703
University of California, Irvine
Craig M. Walsh
Early Translational III
Multiple Sclerosis therapy: Human Pluripotent Stem Cell-Derived Neural Progenitor Cells
$4,535,005
Scripps Research Institute
Peter G. Schultz
Early Translational III
Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis
$2,559,333
University of California, San Francisco
Dr. Arnold Kriegstein
Early Translational III
Human ES cell-derived MGE inhibitory interneuron transplantation for spinal cord injury
$1,623,251
University of California, San Diego
Gene Wei-Ming Yeo
Early Translational III
Molecules to Correct Aberrant RNA Signature in Human Diseased Neurons
$1,532,323
University of California, Santa Cruz
Dr. David Haussler
Training Grant I-3
Training Program in Systems Biology of Stem Cells
$1,133,701
University of California, Santa Barbara
Dr. Dennis O. Clegg
Training Grant I-3
UCSB Stem Cell Biology Training Program
$975,334
Salk Institute for Biological Studies
Juan Carlos Izpisua Belmonte
Training Grant I-3
Training in the Biology of Human Enbryonic Stem Cells and Emerging Technologies
$1,261,333
California Institute of Technology
Paul H. Patterson
Training Grant I-2
Training in Stem Cell Biology at CIT
$1,817,214
Children’s Hospital of Los Angeles
Dr. Donald B. Kohn
Training Grant I-2
Training Grant 1
$2,173,872
Sanford Burnham Prebys Medical Discovery Institute
Dr. Mark Mercola
Training Grant I-2
Burnham Institute CIRM Stem Cell Training Grant (Type II)
$1,061,865
Gladstone Institutes, J. David
Dr. Robert W Mahley
Training Grant I-2
Gladstone CIRM Scholar Program
$2,192,073
Scripps Research Institute
Peter G. Schultz
Training Grant I-2
Training Grant I
$1,021,395
University of California, Davis
Dr. Frederick J Meyers MD
Training Grant I-1
Stem Cell Research Training Grant
$1,780,859
University of California, San Francisco
Dr. Susan J Fisher PhD
Training Grant I-1
Training Grant I
$2,868,145
University of California, Los Angeles
Dr. Owen N Witte M.D.
Training Grant I-1
CIRM Type I Comprehensive Training Program
$3,660,398
University of Southern California
Dr. Robert E Maxson
Training Grant I-1
CIRM Stem Cell Biology Training Grant
$2,332,431
University of California, Irvine
Dr. Peter Bryant
Training Grant I-1
Stem Cell Research Training Grant
$1,935,487
University of California, Berkeley
Randy W. Schekman
Training Grant I-1
Human Stem Cell Training at UC Berkeley and Childrens Hospital of Oakland
$2,360,457
University of California, San Diego
Dr. Lawrence S. B. Goldstein
Training Grant I-1
Interdisciplinary Stem Cell Training Program at UCSD
$3,459,396
Stanford University
Michael T. Longaker M.D.
Training Grant I-1
Stanford CIRM Training Program
$3,035,282
University of California, Davis
Dr Mehrdad Abedi
Disease Team Therapy Planning I
Stem Cell Gene Therapy for HIV in AIDS Lymphoma Patients
$66,880
University of California, Davis
Dr. John Laird
Disease Team Therapy Planning I
Phase I study of IM Injection of VEGF Producing MSC for the Treatment of Critical Limb Ischemia
$76,066
University of California, Davis
Dr. Vicki Wheelock
Disease Team Therapy Planning I
MSC engineered to produce BDNF for the treatment of Huntington’s disease
$97,564
Cedars-Sinai Medical Center
Professor Clive Niels Svendsen
Disease Team Therapy Planning I
Stem Cells Secreting GDNF for the Treatment of ALS
$63,487
Stanford University
Dr. Albert J Wong
Disease Team Therapy Planning I
Recombinant Bispecific Antibody Targeting Cancer Stem Cells for the Therapy of Glioblastoma
$109,750
Stanford University
Dr. Judith A Shizuru
Disease Team Therapy Planning I
A monoclonal antibody that depletes blood stem cells and enables chemotherapy free transplants
$90,147
OncoMed Pharmaceuticals, Inc.
Timothy Hoey
Disease Team Therapy Planning I
Anti-Notch1, OMP-52M51: A New Cancer Therapeutic to Reduce CSC Frequency
$65,120
Cedars-Sinai Medical Center
Dr. Dan Gazit
Disease Team Therapy Planning I
Genetically Engineered Mesenchymal Stem Cells for the Treatment of Vertebral Compression Fractures.
$107,622
StemCells, Inc.
Dr. Alexandra Capela
Disease Team Therapy Planning I
Neuroprotection to treat Alzheimer’s: a new paradigm using human central nervous system cells
$90,101
University of California, Los Angeles
Dr. Stanley Nelson
Disease Team Therapy Planning I
Combination therapy to Enhance Antisense Mediated Exon Skipping for Duchenne Muscular Dystrophy
$68,947
Geron Corporation
Dr. Jane Stephanie Lebkowski Dr.
Disease Team Therapy Planning I
Preclinical Development and First-In-Human Testing of GRNCM1 in Advanced Heart Failure
$0
Sanford Burnham Prebys Medical Discovery Institute
Dr. Marcel Daadi Dr.
Disease Team Therapy Planning I
Neural Stem Cell-Based Therapy For Parkinson’s Disease
$63,952
Sanford Burnham Prebys Medical Discovery Institute
Dr. Stuart A Lipton
Disease Team Therapy Planning I
hESC-derived NPCs Programmed with MEF2C for Cell Transplantation in Parkinson’s Disease
$96,448
University of California, Davis
Nancy E. Lane
Disease Team Therapy Planning I
Increasing the endogenous mesenchymal stem cells to the bone surface to treat osteoporosis
$107,750
« Previous
1
…
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Next »